Genexine (Korea) Price History
095700 Stock | KRW 5,840 210.00 3.47% |
If you're considering investing in Genexine Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genexine stands at 5,840, as last reported on the 1st of December, with the highest price reaching 6,170 and the lowest price hitting 5,810 during the day. Genexine holds Efficiency (Sharpe) Ratio of -0.0295, which attests that the entity had a -0.0295% return per unit of risk over the last 3 months. Genexine exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genexine's Standard Deviation of 4.84, market risk adjusted performance of 0.6884, and Risk Adjusted Performance of (0.03) to validate the risk estimate we provide.
Genexine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Genexine |
Sharpe Ratio = -0.0295
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 095700 |
Estimated Market Risk
5.01 actual daily | 44 56% of assets are more volatile |
Expected Return
-0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genexine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genexine by adding Genexine to a well-diversified portfolio.
Genexine Stock Price History Chart
There are several ways to analyze Genexine Stock price data. The simplest method is using a basic Genexine candlestick price chart, which shows Genexine price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 17, 2024 | 9350.0 |
Lowest Price | November 22, 2024 | 5650.0 |
Genexine December 1, 2024 Stock Price Synopsis
Various analyses of Genexine's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Genexine Stock. It can be used to describe the percentage change in the price of Genexine from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Genexine Stock.Genexine Price Rate Of Daily Change | 0.97 | |
Genexine Price Action Indicator | (255.00) | |
Genexine Price Daily Balance Of Power | (0.58) |
Genexine December 1, 2024 Stock Price Analysis
Genexine Stock Price History Data
The price series of Genexine for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 3700.0 with a coefficient of variation of 13.89. The prices are distributed with arithmetic mean of 6802.73. The median price for the last 90 days is 6380.0. The company had 13:10 stock split on 11th of January 2023.Open | High | Low | Close | Volume | ||
12/01/2024 | 6,050 | 6,170 | 5,810 | 5,840 | ||
11/29/2024 | 6,050 | 6,170 | 5,810 | 5,840 | 234,630 | |
11/28/2024 | 6,030 | 6,120 | 5,950 | 6,050 | 137,583 | |
11/27/2024 | 5,980 | 6,070 | 5,900 | 6,030 | 229,636 | |
11/26/2024 | 6,000 | 6,230 | 5,860 | 5,880 | 439,687 | |
11/25/2024 | 5,650 | 5,880 | 5,630 | 5,880 | 181,386 | |
11/22/2024 | 5,680 | 5,770 | 5,590 | 5,650 | 206,925 | |
11/21/2024 | 5,750 | 5,770 | 5,570 | 5,680 | 215,228 | |
11/20/2024 | 5,810 | 5,990 | 5,720 | 5,730 | 255,246 | |
11/19/2024 | 5,980 | 6,040 | 5,850 | 5,850 | 243,207 | |
11/18/2024 | 6,000 | 6,090 | 5,830 | 5,980 | 196,057 | |
11/15/2024 | 6,050 | 6,100 | 5,860 | 6,000 | 234,289 | |
11/14/2024 | 6,150 | 6,500 | 6,050 | 6,080 | 316,138 | |
11/13/2024 | 6,470 | 6,540 | 6,140 | 6,200 | 346,944 | |
11/12/2024 | 6,900 | 6,970 | 6,440 | 6,480 | 449,577 | |
11/11/2024 | 6,860 | 6,970 | 6,730 | 6,970 | 185,111 | |
11/08/2024 | 6,760 | 7,090 | 6,760 | 6,950 | 259,669 | |
11/07/2024 | 7,030 | 7,070 | 6,660 | 6,760 | 363,987 | |
11/06/2024 | 7,270 | 7,380 | 6,910 | 7,070 | 583,610 | |
11/05/2024 | 7,450 | 7,500 | 7,150 | 7,180 | 359,538 | |
11/04/2024 | 7,370 | 7,470 | 7,140 | 7,450 | 393,387 | |
11/01/2024 | 7,320 | 7,650 | 7,140 | 7,370 | 647,197 | |
10/31/2024 | 7,640 | 7,710 | 7,220 | 7,320 | 731,535 | |
10/30/2024 | 8,090 | 8,090 | 7,830 | 7,850 | 450,479 | |
10/29/2024 | 8,040 | 8,130 | 7,810 | 8,110 | 494,083 | |
10/28/2024 | 8,330 | 8,330 | 7,820 | 8,040 | 942,537 | |
10/25/2024 | 8,800 | 8,840 | 8,100 | 8,400 | 1,201,441 | |
10/24/2024 | 8,490 | 9,450 | 8,450 | 8,900 | 1,959,561 | |
10/23/2024 | 8,970 | 9,680 | 8,570 | 8,800 | 3,820,315 | |
10/22/2024 | 8,850 | 9,930 | 8,380 | 8,650 | 6,648,862 | |
10/21/2024 | 9,500 | 9,510 | 8,720 | 8,980 | 1,846,594 | |
10/18/2024 | 9,660 | 9,950 | 9,220 | 9,350 | 3,947,955 | |
10/17/2024 | 8,200 | 10,230 | 7,430 | 9,350 | 23,034,929 | |
10/16/2024 | 6,200 | 8,170 | 6,200 | 8,170 | 3,900,535 | |
10/15/2024 | 6,240 | 6,370 | 6,230 | 6,290 | 67,100 | |
10/14/2024 | 6,320 | 6,400 | 6,180 | 6,290 | 50,087 | |
10/11/2024 | 6,450 | 6,460 | 6,300 | 6,310 | 61,792 | |
10/10/2024 | 6,420 | 6,490 | 6,330 | 6,400 | 46,716 | |
10/08/2024 | 6,310 | 6,610 | 6,310 | 6,410 | 109,389 | |
10/07/2024 | 6,230 | 6,400 | 6,140 | 6,330 | 71,520 | |
10/04/2024 | 6,100 | 6,250 | 6,080 | 6,200 | 34,415 | |
10/02/2024 | 6,160 | 6,210 | 6,000 | 6,080 | 74,982 | |
09/30/2024 | 6,250 | 6,290 | 6,130 | 6,160 | 68,636 | |
09/27/2024 | 6,410 | 6,520 | 6,300 | 6,300 | 71,792 | |
09/26/2024 | 6,390 | 6,450 | 6,310 | 6,380 | 63,036 | |
09/25/2024 | 6,400 | 6,590 | 6,310 | 6,310 | 72,148 | |
09/24/2024 | 6,330 | 6,570 | 6,290 | 6,360 | 97,912 | |
09/23/2024 | 6,510 | 6,510 | 6,310 | 6,330 | 59,442 | |
09/20/2024 | 6,400 | 6,440 | 6,280 | 6,370 | 86,995 | |
09/19/2024 | 6,140 | 6,350 | 6,140 | 6,290 | 89,775 | |
09/13/2024 | 6,230 | 6,290 | 6,090 | 6,140 | 90,295 | |
09/12/2024 | 6,220 | 6,410 | 6,030 | 6,280 | 241,749 | |
09/11/2024 | 6,210 | 6,400 | 6,200 | 6,210 | 66,900 | |
09/10/2024 | 6,260 | 6,340 | 6,170 | 6,200 | 80,050 | |
09/09/2024 | 5,910 | 6,810 | 5,910 | 6,260 | 379,600 | |
09/06/2024 | 6,280 | 6,350 | 6,080 | 6,080 | 95,036 | |
09/05/2024 | 6,430 | 6,460 | 6,220 | 6,270 | 79,965 | |
09/04/2024 | 6,560 | 6,600 | 6,320 | 6,420 | 115,275 | |
09/03/2024 | 6,910 | 6,910 | 6,620 | 6,630 | 72,681 | |
09/02/2024 | 7,070 | 7,090 | 6,780 | 6,820 | 88,948 | |
08/30/2024 | 6,910 | 7,140 | 6,910 | 7,070 | 77,776 |
About Genexine Stock history
Genexine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genexine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genexine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genexine stock prices may prove useful in developing a viable investing in Genexine
Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in South Korea. Genexine, Inc. was founded in 1999 and is based in Seongnam, South Korea. Genexine is traded on Korean Securities Dealers Automated Quotations in South Korea.
Genexine Stock Technical Analysis
Genexine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
All Next | Launch Module |
Genexine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genexine's price direction in advance. Along with the technical and fundamental analysis of Genexine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genexine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.22) | |||
Total Risk Alpha | (1.08) | |||
Treynor Ratio | 0.6784 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Genexine Stock analysis
When running Genexine's price analysis, check to measure Genexine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genexine is operating at the current time. Most of Genexine's value examination focuses on studying past and present price action to predict the probability of Genexine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genexine's price. Additionally, you may evaluate how the addition of Genexine to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |